Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 12/20 | 0.81 |
| ▸ | CNR2 | P34972 | 9/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.75 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.75 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.75 |
| ▸ | MLNR | O43193 | 1/20 | 0.75 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.75 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.75 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.75 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.75 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.75 |
| ▸ | DRD1 | P21728 | 1/20 | 0.75 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.75 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.75 |
| ▸ | HRH2 | P25021 | 1/20 | 0.75 |
| ▸ | HTR2A | P28223 | 1/20 | 0.75 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.75 |
| ▸ | CCKAR | P32238 | 1/20 | 0.75 |
| ▸ | CCKBR | P32239 | 1/20 | 0.75 |
| ▸ | MC4R | P32245 | 1/20 | 0.75 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2633165 | 0.95 | CNR1 (0.77) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL4909775 | 0.95 | CNR1 (0.77) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL12053804 | 0.94 | CNR1 (0.85) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL10145280 | 0.93 | CNR1 (0.73) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL4913336 | 0.93 | CNR1 (0.79) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL12053842 | 0.92 | CNR1 (0.72) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL12062842 | 0.92 | CNR1 (0.72) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL7768479 | 0.91 | CNR1 (0.74) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL14815936 | 0.91 | CNR1 (0.77) | CNR1CNR2CYP2C9GPR55ABCC4 | |
| SCHEMBL5160340 | 0.91 | CNR1 (0.90) | CNR1CNR2CYP2C9GPR55ABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2632919-B1 | PYRAZOLE COMPOUNDS | NATIONAL HEALTH RES INST (TW) | 2018-11-07 | — | — | EP | disclosed |
| CN-103459383-B | pyrazole compound | 财团法人国家卫生研究院 | 2016-06-22 | — | — | CN | disclosed |
| US-8962845-B2 | Pyrazole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2015-02-24 | — | — | US | disclosed |
| US-8962845-B2 | Pyrazole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2015-02-24 | — | — | US | disclosed |
| US-8962845-B2 | Pyrazole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2015-02-24 | — | — | US | disclosed |
| CN-103459383-A | Pyrazole compound | NAT HEALTH RESEARCH INSTITUTES | 2013-12-18 | — | — | CN | disclosed |
| US-20130085126-A1 | PYRAZOLE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2013-04-04 | — | — | US | disclosed |
| US-20130085126-A1 | PYRAZOLE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2013-04-04 | — | — | US | disclosed |
| US-20130085126-A1 | PYRAZOLE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2013-04-04 | — | — | US | disclosed |
| WO-2013048989-A2 | PYRAZOLE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2013-04-04 | — | — | WO | disclosed |
| EP-0876350-B1 | PYRAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES | SANOFI SYNTHELABO (FR) | 2001-07-11 | — | — | EP | disclosed |
| US-6028084-A | Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives | SANOFI-SYNTHELABO (FR) | 2000-02-22 | — | — | US | disclosed |
| EP-0876350-A1 | PYRAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES | SANOFI (FR) | 1998-11-11 | — | — | EP | disclosed |
| WO-1997019063-A1 | PYRAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES | SANOFI (FR) | 1997-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085126-A1 | PYRAZOLE COMPOUNDS | CYP3A43, CYP3A4, CYP3A7 | CNR1 353/4885CNR2 572/4885CYP2C9 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.